In this Sept. 6, 2017 photo provided by the National Oceanic and Atmospheric Administration (NOAA), fish swim in a reef at Pearl and Hermes Atoll in the Northwestern Hawaiian Islands. A decade-long effort by the world to save the world’s disappearing species and declining ecosystems has mostly failed so far, with fragile ecosystems like coral reefs and tropical forests in even more trouble than ever, according to a United Nations biodiversity report released on Tuesday, Sept. 15, 2020. (Jacob Asher/NOAA via AP)
By Christina Larson and Seth Borenstein
A decade-long global effort to save Earth's disappearing species and declining ecosystems have mostly stumbled, with fragile habitats like coral reefs and tropical forests in more trouble than ever, researchers said in a report Tuesday.
In 2010, more than 150 countries agreed to goals to protect nature, but the new United Nations scorecard found that the world has largely failed to meet 20 different targets to safeguard species and ecosystems.
Six of those 20 goals were "partially achieved," and the rest were not.
If this were a school and these were tests, the world has flunked, said Elizabeth Maruma Mrema, executive secretary of the U.N. Convention on Biological Diversity, which released the report.
Inger Andersen, who leads the U.N. environment program, called it a global failure.
"From COVID-19 to massive wildfires, floods, melting glaciers and unprecedented heat, our failure to meet the Aichi (biodiversity) targets — protect our home — has very real consequences," Andersen said. "We can no longer afford to cast nature to the side."
In a Tuesday interview with The Associated Press, former U.N. Secretary-General Ban Ki-Moon connected the problems to "a lack of global partnership and political leadership." He said multilateralism has been under attack, citing the United States' withdrawal from the Paris climate change agreement as an example.
The U.N. team and report authors said the study is not meant to stoke despair, but to galvanize governments to take stronger actions over the next decade to protect the diversity of life.
"Some progress has been made, but inadequate progress. A lot still needs to be done," Mrema said. "The key is to get the political will and the commitment."
Duke University ecologist Stuart Pimm, who was not involved in the new report, said it's good that countries are getting together to examine their biodiversity goals but some of the targets are nebulous. Reducing "everything on the planet to single scores" obscures the fact that the picture may look different in different places, he said.
For years, conservation activists have used the polar bear as a poster child for species in trouble — especially those threatened by climate change, which the report connects to biodiversity loss. But Mrema and lead author David Cooper said the world should think about a different poster animal: humans.
"A lot of things civilizations depend on are certainly threatened," he said.
The report was originally slated to be released at a U.N. conference to set biodiversity targets for the next decade, but the event in Kunming, China, was postponed until next year due to the pandemic.
Last week, the World Wide Fund for Nature released new research detailing how monitored populations of mammals, birds, amphibians, reptiles and fish have declined, on average, 68 percent, between 1970 and 2016.
"With pandemic deaths surging and wildfires raging across the entire West Coast, never have the consequences of our misuse and abuse of the natural world been more clear," said Julia Baum, a biologist at Canada's University of Victoria who wasn't part of the report.
As countries prepare to restart their economies after combating the coronavirus, there's an opportunity to do better — or much worse — for the planet, Cooper said.
"Some countries are relaxing environmental regulations, but others are investing in a green recovery," he said.
One of the challenges in meeting global biodiversity targets is a mismatch between countries with abundant natural assets — such as large tracts of intact tropical forests — and those with money to enforce protections.
"The biodiversity hotspots tend to be in poorer countries," and wealthy countries need to be willing to provide financial or practical support to help other nations, Cooper said.
Dalhousie University marine biologist Boris Worm, who also wasn't part of the report, said the world is at a crossroads.
"We still have the chance to save most of the world's endangered species and vulnerable ecosystems," Worm said. "Now we face a historic choice to either seize this opportunity, and rebuild what has been lost, or to let the world's species slide further into oblivion."
He said it's striking that Earth's biodiversity took millions of years to evolve, "yet we could destroy much of it in a matter of decades — or safeguard it for generations to come."
"It's our choice," he added.
___
AP writer Elias Meseret contributed from Addis Ababa, Ethiopia.
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
The boys discuss President Biden's plans to send out free rapid tests as the testing supply chain starts to buckle ahead of the holidays. Also, why aren't Americans having more babies, and The Matrix returns.
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
